Showing 17–32 of 51 results
-
Add to cartAttribute Specification Brand Name Mounjaro Active Ingredient Tirzepatide Dosage Strength 7.5mg / 0.5mL Medication Class GIP and GLP-1 Receptor Agonist Administration Route Subcutaneous Injection (Once-Weekly) Primary Indication Chronic Weight Management & Type 2 Diabetes Manufacturer Eli Lilly Packaging Variant Pre-filled KwikPen / Single-dose Vials Storage Temperature Refrigerated at 2°C to 8°C (Do not freeze) -
Add to cartFeature Specification Details Active Ingredient Tirzepatide (Dual GIP / GLP-1 Receptor Agonist) Bundle Contents 1 x 2.5mg KwikPen (4 doses) + 1 x 5mg KwikPen (4 doses) Total Duration 8 Weeks of continuous medical treatment Administration Route Subcutaneous injection (Once weekly) Storage Protocols Refrigerate at 2°C – 8°C; Unrefrigerated stable up to 30 days below 30°C Target Indications Chronic weight management, metabolic support, and obesity care -
Add to cartFeature Details Product Name Mounjaro Starter Pack Bundle Active Ingredient Tirzepatide Dose Concentrations 2.5mg, 5mg, and 7.5mg Mechanism of Action Dual GIP and GLP-1 Receptor Agonist Administration Route Subcutaneous Injection (Once-Weekly) Primary Indication Chronic Weight Management & Type 2 Diabetes Support Packaging Multi-dose pre-filled injection pens Storage Temperature Refrigerated at 2°C to 8°C (Do not freeze) -
Add to cartAttribute Specification Product Name Mounjaro Bundles (Maintenance & Escalation Phase) Available Strengths 5mg / 0.5mL and 7.5mg / 0.5mL Active Ingredient Tirzepatide (Dual GIP and GLP-1 Receptor Agonist) Administration Route Subcutaneous Injection (Once-Weekly) Primary Indication Chronic Weight Management & Type 2 Diabetes Adjunct Packaging Configuration Multi-dose pre-filled injection pens (4-week supply per strength) Storage Requirements Refrigerated storage ($2^\circ\text{C}$ to $8^\circ\text{C}$), do not freeze -
Select options This product has multiple variants. The options may be chosen on the product pageProduct Characteristic Specification Details Active Ingredient Tirzepatide Therapeutic Class Dual GIP and GLP-1 Receptor Agonist Primary Indication Chronic Weight Management & Metabolic Support Administration Route Subcutaneous Injection (Once Weekly) Available Strengths 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg Storage Instructions Refrigerate between 2°C to 8°C; do not freeze -
Add to cartFeature Specification Product Name Mysimba Active Ingredients Naltrexone hydrochloride (8 mg) / Bupropion hydrochloride (90 mg) Dosage Form Prolonged-release tablets Primary Indication Chronic weight management in adults Mechanism Targets central nervous system pathways regulating food intake and energy expenditure Manufacturer Central Medical Supplies / Approved European Distributors -
Select options This product has multiple variants. The options may be chosen on the product pageThis is a variable product.
Etiam bibendum elit eget erat. Curabitur bibendum justo non orci. Cras elementum. In dapibus augue non sapien. Morbi imperdiet, mauris ac auctor dictum, nisl ligula egestas nulla, et sollicitudin sem purus in lacus. Praesent dapibus.
-
Select options This product has multiple variants. The options may be chosen on the product pageSpecification Details Product Name Orlistat 120mg Capsules Active Ingredient Orlistat (120mg) Therapeutic Class Peripherally Acting Anti-obesity Compound (Lipase Inhibitor) Primary Indication Clinical Obesity Management and Weight Reduction Mechanism of Action Inhibits gastric and pancreatic lipases to block 30% of dietary fat absorption Dosage Form Hard Gelatin Capsules Standard Dosage One capsule taken with water immediately before, during, or up to one hour after each main meal containing fat (Maximum 3 times daily) Target Population Adults with a BMI $\ge 30$, or BMI $\ge 28$ with associated risk factors (e.g., hypertension, type 2 diabetes) Shipping & Packaging Secure, patient-centric packaging with overnight discreet delivery -
Add to cartSpecification Product Details Product Name Ozempic 0.5mg Pre-filled Pen Active Ingredient Semaglutide (GLP-1 receptor agonist) Strength / Dosage 0.5mg per maintenance dose Primary Indication Type 2 Diabetes Mellitus management Secondary Benefits Weight management support, cardiovascular risk reduction Administration Route Subcutaneous injection (Once-weekly) Storage Requirements Refrigerate new pens ($2^\circ\text{C} – 8^\circ\text{C}$). In-use pens store below $30^\circ\text{C}$ for up to 56 days. Manufacturer Novo Nordisk -
Select options This product has multiple variants. The options may be chosen on the product page
This is a simple product.
Nulla pulvinar eleifend sem. Sed vel lectus. Donec odio tempus molestie, porttitor ut, iaculis quis, sem. Mauris metus. Curabitur vitae diam non enim vestibulum interdum. Aenean id metus id velit ullamcorper pulvinar. Etiam sapien elit, consequat eget, tristique non, venenatis quis, ante. Integer vulputate sem a nibh rutrum consequat.
-
Add to cartSpecification Details Product Name Retatrutide Injection Pen Kit Concentration 40mg Form Type Prefilled Injection Pen Primary Indication Chronic Weight Management & Metabolic Support Mechanism of Action Triple Hormone Receptor Agonist (GIP, GLP-1, Glucagon) Storage Temperature Refrigerated at 2°C to 8°C (Do not freeze) Administration Route Subcutaneous Injection -
Add to cartSpecification Details Product Name Rybelsus 14mg Active Ingredient Semaglutide (14 mg) Manufacturer Novo Nordisk Dosage Form Oral Tablets Pack Size 30 Tablets (1-Month Supply) Therapeutic Class GLP-1 Receptor Agonist Primary Indication Type 2 Diabetes Mellitus Management Secondary Benefits Weight Management & Appetite Regulation Storage Conditions Store below 30°C in original blister pack to protect from moisture -
Add to cartSpecification Product Details Brand Name Rybelsus Active Ingredient Semaglutide (GLP-1 receptor agonist) Strength 3 mg per tablet Pack Size 30 tablets per box Dosage Form Oral Tablet Primary Indication Type 2 Diabetes Mellitus Management Secondary Benefits Glycemic control, metabolic support, and weight management Manufacturer Novo Nordisk Storage Requirements Store below 30°C in original packaging to protect from moisture -
Add to cartSpecification Product Details Brand Name Rybelsus Active Ingredient Semaglutide Strength 7mg Quantity 30 Tablets (1-month supply) Dosage Form Oral Tablet Manufacturer Novo Nordisk Primary Indication Type 2 Diabetes Mellitus Management Secondary Benefits Appetite Regulation and Weight Management
